MI-503

CAT:
804-HY-16925-01
Size:
2 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
MI-503 - image 1

MI-503

  • UNSPSC Description:

    MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.
  • Target Antigen:

    Epigenetic Reader Domain
  • Type:

    Reference compound
  • Related Pathways:

    Epigenetics
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/MI-503.html
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic)
  • Smiles:

    FC(F)(F)CC(S1)=CC2=C1N=CN=C2NC3CCN(CC4=CC=C(N(CC5=CNN=C5)C(C#N)=C6)C6=C4C)CC3
  • Molecular Weight:

    564.63
  • References & Citations:

    [1]Borkin D, et al. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo. Cancer Cell. 2015 Apr 13;27(4):589-602.
  • Shipping Conditions:

    Room Temperature
  • Clinical Information:

    No Development Reported
  • CAS Number:

    1857417-13-0